China Liposome Drug Delivery Market Research Report 2017

January 2017 | 121 pages | ID: CDCDCE41C12EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Liposome Drug Delivery

Revenue, means the sales value of Liposome Drug Delivery

This report studies Liposome Drug Delivery in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Johnson & Johnson
• Gilead Sciences
• Luye Pharma
• Sun Pharmaceutical
• Pacira
• Fudan-Zhangjiang
• Sigma-Tau Group
• Teva Pharmaceutical
• CSPC
• Novartis
• Crucell
• Celsion Corporation
• Kingond Pharm
• Shanghai New Asia
• Spectrum Pharmaceuticals

Market Segment by Regions (provinces), covering

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Liposomal doxorubicin
• Liposomal Amphoteracin B
• Liposomal Paclitaxel
• Other

Split by Application, this report focuses on consumption, market share and growth rate of Liposome Drug Delivery in each application, can be divided into

• Fungal Infection Therapy
• Cancer Therapy ( Tumor therapy)
• Other

Contents

China Liposome Drug Delivery Market Research Report 2017

1 LIPOSOME DRUG DELIVERY MARKET OVERVIEW

1.1 Product Overview and Scope of Liposome Drug Delivery
1.2 Liposome Drug Delivery Segment by Type
  1.2.1 China Production Market Share of Liposome Drug Delivery Type in 2015
  1.2.2 Liposomal doxorubicin
  1.2.3 Liposomal Amphoteracin B
  1.2.4 Liposomal Paclitaxel
  1.2.5 Other
1.3 Applications of Liposome Drug Delivery
  1.3.1 Liposome Drug Delivery Consumption Market Share by Application in 2015
  1.3.2 Fungal Infection Therapy
  1.3.3 Cancer Therapy ( Tumor therapy)
  1.3.4 Other
1.4 China Market Size (Value) of Liposome Drug Delivery (2011-2021)
1.5 China Liposome Drug Delivery Status and Outlook
1.6 Government Policies

2 CHINA LIPOSOME DRUG DELIVERY MARKET COMPETITION BY MANUFACTURERS

2.1 China Liposome Drug Delivery Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Liposome Drug Delivery Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Liposome Drug Delivery Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Liposome Drug Delivery Manufacturing Base Distribution, Sales Area, Product Type
2.5 Liposome Drug Delivery Market Competitive Situation and Trends
  2.5.1 Liposome Drug Delivery Market Concentration Rate
  2.5.2 Liposome Drug Delivery Market Share of Top 3 and Top 5 Manufacturers

3 CHINA LIPOSOME DRUG DELIVERY MANUFACTURERS PROFILES/ANALYSIS

3.1 Johnson & Johnson
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 Liposome Drug Delivery Product Type, Application and Specification
    3.1.2.1 Liposomal doxorubicin
    3.1.2.2 Liposomal Amphoteracin B
  3.1.3 Johnson & Johnson Liposome Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 Gilead Sciences
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 Liposome Drug Delivery Product Type, Application and Specification
    3.2.2.1 Liposomal doxorubicin
    3.2.2.2 Liposomal Amphoteracin B
  3.2.3 Gilead Sciences 121 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 Luye Pharma
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 Liposome Drug Delivery Product Type, Application and Specification
    3.3.2.1 Liposomal doxorubicin
    3.3.2.2 Liposomal Amphoteracin B
  3.3.3 Luye Pharma 128 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 Sun Pharmaceutical
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Liposome Drug Delivery Product Type, Application and Specification
    3.4.2.1 Liposomal doxorubicin
    3.4.2.2 Liposomal Amphoteracin B
  3.4.3 Sun Pharmaceutical Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 Pacira
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Liposome Drug Delivery Product Type, Application and Specification
    3.5.2.1 Liposomal doxorubicin
    3.5.2.2 Liposomal Amphoteracin B
  3.5.3 Pacira Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview
3.6 Fudan-Zhangjiang
  3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.6.2 Liposome Drug Delivery Product Type, Application and Specification
    3.6.2.1 Liposomal doxorubicin
    3.6.2.2 Liposomal Amphoteracin B
  3.6.3 Fudan-Zhangjiang Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.6.4 Main Business/Business Overview
3.7 Sigma-Tau Group
  3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.7.2 Liposome Drug Delivery Product Type, Application and Specification
    3.7.2.1 Liposomal doxorubicin
    3.7.2.2 Liposomal Amphoteracin B
  3.7.3 Sigma-Tau Group Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.7.4 Main Business/Business Overview
3.8 Teva Pharmaceutical
  3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.8.2 Liposome Drug Delivery Product Type, Application and Specification
    3.8.2.1 Liposomal doxorubicin
    3.8.2.2 Liposomal Amphoteracin B
  3.8.3 Teva Pharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.8.4 Main Business/Business Overview
3.9 CSPC
  3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.9.2 Liposome Drug Delivery Product Type, Application and Specification
    3.9.2.1 Liposomal doxorubicin
    3.9.2.2 Liposomal Amphoteracin B
  3.9.3 CSPC Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.9.4 Main Business/Business Overview
3.10 Novartis
  3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.10.2 Liposome Drug Delivery Product Type, Application and Specification
    3.10.2.1 Liposomal doxorubicin
    3.10.2.2 Liposomal Amphoteracin B
  3.10.3 Novartis Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.10.4 Main Business/Business Overview
3.11 Crucell
3.12 Celsion Corporation
3.13 Kingond Pharm
3.14 Shanghai New Asia
3.15 Spectrum Pharmaceuticals

4 CHINA LIPOSOME DRUG DELIVERY CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2011-2016)

4.1 China Liposome Drug Delivery Capacity, Production and Growth (2011-2016)
4.2 China Liposome Drug Delivery Revenue and Growth (2011-2016)
4.3 China Liposome Drug Delivery Production, Consumption, Export and Import (2011-2016)

5 CHINA LIPOSOME DRUG DELIVERY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Liposome Drug Delivery Production and Market Share by Type (2011-2016)
5.2 China Liposome Drug Delivery Revenue and Market Share by Type (2011-2016)
5.3 China Liposome Drug Delivery Price by Type (2011-2016)
5.4 China Liposome Drug Delivery Production Growth by Type (2011-2016)

6 CHINA LIPOSOME DRUG DELIVERY MARKET ANALYSIS BY APPLICATION

6.1 China Liposome Drug Delivery Consumption and Market Share by Application (2011-2016)
6.2 China Liposome Drug Delivery Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 CHINALIPOSOME DRUG DELIVERY MARKET ANALYSIS BY REGIONS (PROVINCES)

7.1 China Liposome Drug Delivery Production, Production Value and Price by Regions (Provinces)(2011-2016)
  7.1.1 China Liposome Drug Delivery Production and Market Share by Regions (Provinces)(2011-2016)
  7.1.2 China Liposome Drug Delivery Production Value and Market Share by Regions (Provinces)(2011-2016)
  7.1.3 China Liposome Drug Delivery Sales Price by Regions (Provinces)(2011-2016)
7.2 China Liposome Drug Delivery Consumption by Regions (Provinces)(2011-2016)
7.3 China Liposome Drug Delivery Production, Consumption, Export and Import (2011-2016)

8 LIPOSOME DRUG DELIVERY MANUFACTURING COST ANALYSIS

8.1 Liposome Drug Delivery Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Liposome Drug Delivery

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Liposome Drug Delivery Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Liposome Drug Delivery Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 CHINA LIPOSOME DRUG DELIVERY MARKET FORECAST (2016-2021)

12.1 China Liposome Drug Delivery Capacity, Production, Revenue Forecast (2016-2021)
12.2 China Liposome Drug Delivery Production, Import, Export and Consumption Forecast (2016-2021)
12.3 China Liposome Drug Delivery Production Forecast by Type (2016-2021)
12.4 China Liposome Drug Delivery Consumption Forecast by Application (2016-2021)
12.5 China Liposome Drug Delivery Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
  12.5.1 China Liposome Drug Delivery Production Forecast by Regions (Provinces)(2016-2021)
  12.5.2 China Liposome Drug Delivery Consumption Forecast by Regions (Provinces)(2016-2021)
  12.5.3 China Liposome Drug Delivery Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.6 Liposome Drug Delivery Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Liposome Drug Delivery
Figure China Production Market Share of Liposome Drug Delivery by Type in 2015
Figure Product Picture of Liposomal doxorubicin
Table Major Manufacturers of Liposomal doxorubicin
Figure Product Picture of Liposomal Amphoteracin B
Table Major Manufacturers of Liposomal Amphoteracin B
Figure Product Picture of Liposomal Paclitaxel
Table Major Manufacturers of Liposomal Paclitaxel
Figure Product Picture of Other
Table Major Manufacturers of Other
Table Liposome Drug Delivery Consumption Market Share by Application in 2015
Figure Fungal Infection Therapy Examples
Figure Cancer Therapy ( Tumor therapy) Examples
Figure Other Examples
Figure China Liposome Drug Delivery Revenue (Million USD) and Growth Rate (2011-2021)
Table China Liposome Drug Delivery Capacity of Key Manufacturers (2015 and 2016)
Table China Liposome Drug Delivery Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Liposome Drug Delivery Capacity of Key Manufacturers in 2015
Figure China Liposome Drug Delivery Capacity of Key Manufacturers in 2016
Table China Liposome Drug Delivery Production of Key Manufacturers (2015 and 2016)
Table China Liposome Drug Delivery Production Share by Manufacturers (2015 and 2016)
Figure 2015 Liposome Drug Delivery Production Share by Manufacturers
Figure 2016 Liposome Drug Delivery Production Share by Manufacturers
Table China Liposome Drug Delivery Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Liposome Drug Delivery Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Liposome Drug Delivery Revenue Share by Manufacturers
Table 2016 China Liposome Drug Delivery Revenue Share by Manufacturers
Table China Market Liposome Drug Delivery Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Liposome Drug Delivery Average Price of Key Manufacturers in 2015
Table Manufacturers Liposome Drug Delivery Manufacturing Base Distribution and Sales Area
Table Manufacturers Liposome Drug Delivery Product Type
Figure Liposome Drug Delivery Market Share of Top 3 Manufacturers
Figure Liposome Drug Delivery Market Share of Top 5 Manufacturers
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Liposome Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Liposome Drug Delivery Market Share (2011-2016)
Table Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gilead Sciences Liposome Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Gilead Sciences Liposome Drug Delivery Market Share (2011-2016)
Table Luye Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Luye Pharma Liposome Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Luye Pharma Liposome Drug Delivery Market Share (2011-2016)
Table Sun Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sun Pharmaceutical Liposome Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sun Pharmaceutical Liposome Drug Delivery Market Share (2011-2016)
Table Pacira Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pacira Liposome Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pacira Liposome Drug Delivery Market Share (2011-2016)
Table Fudan-Zhangjiang Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Fudan-Zhangjiang Liposome Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Fudan-Zhangjiang Liposome Drug Delivery Market Share (2011-2016)
Table Sigma-Tau Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sigma-Tau Group Liposome Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sigma-Tau Group Liposome Drug Delivery Market Share (2011-2016)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Liposome Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Pharmaceutical Liposome Drug Delivery Market Share (2011-2016)
Table CSPC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSPC Liposome Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure CSPC Liposome Drug Delivery Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Liposome Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Liposome Drug Delivery Market Share (2011-2016)
Table Crucell Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celsion Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kingond Pharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shanghai New Asia Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Spectrum Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Liposome Drug Delivery Capacity, Production and Growth (2011-2016)
Figure China Liposome Drug Delivery Revenue (Million USD) and Growth (2011-2016)
Table China Liposome Drug Delivery Production, Consumption, Export and Import (2011-2016)
Table China Liposome Drug Delivery Production by Type (2011-2016)
Table China Liposome Drug Delivery Production Share by Type (2011-2016)
Figure Production Market Share of Liposome Drug Delivery by Type (2011-2016)
Figure 2015 Production Market Share of Liposome Drug Delivery by Type
Table China Liposome Drug Delivery Revenue by Type (2011-2016)
Table China Liposome Drug Delivery Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Liposome Drug Delivery by Type (2011-2016)
Figure 2015 Revenue Market Share of Liposome Drug Delivery by Type
Table China Liposome Drug Delivery Price by Type (2011-2016)
Figure China Liposome Drug Delivery Production Growth by Type (2011-2016)
Table China Liposome Drug Delivery Consumption by Application (2011-2016)
Table China Liposome Drug Delivery Consumption Market Share by Application (2011-2016)
Figure China Liposome Drug Delivery Consumption Market Share by Application in 2015
Table China Liposome Drug Delivery Consumption Growth Rate by Application (2011-2016)
Figure China Liposome Drug Delivery Consumption Growth Rate by Application (2011-2016)
Table China Liposome Drug Delivery Production by Regions (Provinces)(2011-2016)
Table China Liposome Drug Delivery Production Market Share by Regions (Provinces)(2011-2016)
Table China Liposome Drug Delivery Production Value by Regions (Provinces)(2011-2016)
Table China Liposome Drug Delivery Production Value Market Share by Regions (Provinces)(2011-2016)
Table China Liposome Drug Delivery Sales Price by Regions (Provinces)(2011-2016)
Table China Liposome Drug Delivery Consumption by Regions (Provinces)(2011-2016)
Table China Liposome Drug Delivery Consumption Market Share by Regions (Provinces)(2011-2016)
Table China Liposome Drug Delivery Production, Consumption, Export and Import (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Liposome Drug Delivery
Figure Manufacturing Process Analysis of Liposome Drug Delivery
Figure Liposome Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of Liposome Drug Delivery Major Manufacturers in 2015
Table Major Buyers of Liposome Drug Delivery
Table Distributors/Traders List
Figure China Liposome Drug Delivery Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Liposome Drug Delivery Revenue and Growth Rate Forecast (2016-2021)
Table China Liposome Drug Delivery Production, Import, Export and Consumption Forecast (2016-2021)
Table China Liposome Drug Delivery Production Forecast by Type (2016-2021)
Table China Liposome Drug Delivery Consumption Forecast by Application (2016-2021)
Table China Liposome Drug Delivery Production Forecast by Regions (Provinces)(2016-2021)
Table China Liposome Drug Delivery Consumption Forecast by Regions (Provinces)(2016-2021)
Table China Liposome Drug Delivery Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)